SK Biopharmaceuticals Co., Ltd.
Seongnam, Republic of Korea
Dr. Mijin Moon, PhD is Team Leader of Oncology Research Team 1 at the SK Biopharmaceuticals Cancer Research Center in Seongnam, Republic of Korea.
Dr. Moon's team is active in researchig novel compounds for the targeted treatment of various cancers, including SKL27969, a brain-penetrating small-molecule inhibitor of PRMT5 with potent antitumor activity in glioblastoma and brain metastasis preclinical models.